Korean J Pain.  2015 Apr;28(2):156-157. 10.3344/kjp.2015.28.2.156.

Combined Use of Intrathecal Opioids and Dexmedetomidine in the Management of Neuropathic Pain

• Ghobadifar MA
• Pourghashdar F
• Akbarzadeh A
• Mosallanejad Z

• KMID: 2278282
• DOI: http://doi.org/10.3344/kjp.2015.28.2.156

Abstract

No abstract available.

MeSH Terms

Analgesics, Opioid*
Dexmedetomidine*
Neuralgia*
Analgesics, Opioid
Dexmedetomidine

Reference

1. Kim KH. Safe sedation and hypnosis using dexmedetomidine for minimally invasive spine surgery in a prone position. Korean J Pain. 2014; 27:313–320. PMID: 25317279.

2. Ghobadifar MA, Kalani N. The potential role of intrathecal nefopam in the management of neuropathic pain. Korean J Pain. 2014; 27:301–302. PMID: 25031820.

3. Harden RN, Argoff CE, Williams DA. Intrathecal opioids for chronic pain: a call for evidence. Pain Med. 2014; 15:1823–1824. PMID: 25279707.

4. Mavropoulos G, Minguet G, Brichant JF. Alpha-2 adrenoreceptor agonists in anaesthesia and intensive care medicine. Rev Med Liege. 2014; 69:97–101. PMID: 24683831.

5. Işgüzar O, Bariş S, Bozkurt A, Can B, Bilge S, Türe H. Evaluation of antinociceptive and neurotoxic effects of intrathecal dexmedetomidine in rats. Balkan Med J. 2012; 29:354–357. PMID: 25207033.

6. Kabalak A, Ekmekçioğlu E, Ceylan A, Kahveci K. The synergistic antinociceptive interactions of morphine and dexmedetomidine in rats with nerve-ligation injury. Hippokratia. 2013; 17:326–331. PMID: 25031511.